Parvovirus B19 nonstructural Protein-Induced damage of cellular DNA and resultant apoptosis

International Journal of Medical Sciences

Volumn 8, Issue 2, 2011, Pages 88-96

  Poole, Brian D ^a,b   Kivovich, Violetta ^a,c,d   Gilbert, Leona ^c,d   Naides, Stanley J ^a,c,e  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b BRIGHAM YOUNG UNIVERSITY   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF JYVÄSKYLÄ   (Finland)

^e QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

Apoptosis; Autoantibody; DNA damage and repair; Fulminant liver failure; Parvovirus B19; Systemic lupus erythematosus

Indexed keywords

ATM PROTEIN; ATR PROTEIN; CELL DNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SINGLE STRANDED DNA; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; COVALENT BOND; CYTOTOXICITY; DNA DAMAGE; DNA REPAIR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN PARVOVIRUS B19; LIVER CELL; PROTEIN BINDING; SINGLE STRANDED DNA BREAK; VIRUS GENOME;

EID: 79951779172     PISSN: None     EISSN: 14491907     Source Type: Journal    
DOI: 10.7150/ijms.8.88     Document Type: Article

References (63)

1. Anderson MJ, Jones SE, Fisher-Hoch SP, Lewis E, Hall SM, Bartlett CL, et al. Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet 1983;1(8338):1378.
2. Naides SJ, Scharosch LL, Foto F, Howard EJ. Rheumatologic manifestations of human parvovirus B19 infection in adults. Initial two-year clinical experience. Arthritis Rheum 1990;33(9):1297-309.
3. Lunardi C, Tiso M, Borgato L, Nanni L, Millo R, De Sandre G, et al. Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties. Eur J Immunol 1998;28(3):936-48.
4. Hansen KE, Arnason J, Bridges AJ. Autoantibodies and common viral illnesses. Semin Arthritis Rheum 1998;27(5):263-71.
5. Jones LP, Erdman DD, Anderson LJ. Prevalence of antibodies to human parvovirus B19 nonstructural protein in persons with various clinical outcomes following B19 infection. J Infect Dis 1999;180(2):500-4.
6. Cubel RC, Valadao MC, Pereira WV, Magalhaes MC, Nascimento JP. Aplastic crisis due to human parvovirus B19 infection in hereditary hemolytic anaemia. Rev Inst Med Trop Sao Paulo 1992;34(5):479-82.
7. Dutta U, Mittal S, Ratho RK, Das A. Acute liver failure and severe hemophagocytosis secondary to parvovirus B19 infection. Indian J Gastroenterol 2005;24(3):118-9.
8. Ho JK, Tha SP, Coupland R, Dalal BI, Bowie WR, Sreenivasan GM, et al. Parvovirus B19 in an immunocompetent adult patient with acute liver failure: an underdiagnosed cause of acute non-A-E viral hepatitis. Can J Gastroenterol 2005;19(3):161-2.
9. Karetnyi YV, Beck PR, Markin RS, Langnas AN, Naides SJ. Human parvovirus B19 infection in acute fulminant liver failure. Arch Virol 1999;144(9):1713-24.
10. Kishore J, Sen M. Parvovirus B19-induced thrombocytopenia and anemia in a child with fatal fulminant hepatic failure coinfected with hepatitis A and E viruses. J Trop Pediatr 2009 Oct;55(5):335-7.
11. Langnas AN, Markin RS, Cattral MS, Naides SJ. Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia. Hepatology 1995;22(6):1661-5.
12. Lee WM, Brown KE, Young NS, Dawson GJ, Schlauder GG, Gutierrez RA, et al. Brief report: no evidence for parvovirus B19 or hepatitis E virus as a cause of acute liver failure. Dig Dis Sci 2006;51(10):1712-5.
13. Ozcay F, Bikmaz YE, Canan O, Ozbek N. Hepatitis A and parvovirus B19 infections in an infant with fulminant hepatic failure. Turk J Gastroenterol 2006;17(2):148-50.
14. Pardi DS, Romero Y, Mertz LE, Douglas DD. Hepatitis- associated aplastic anemia and acute parvovirus B19 infection: a report of two cases and a review of the literature. Am J Gastroenterol 1998;93(3):468-70.
15. So K, Macquillan G, Garas G, Delri vi ere L, Mitchell A, Speers D, et al. Urgent liver transplantation for acute liver failure due to parvovirus B19 infection complicated by primary Epstein-Barr virus and cytomegalovirus infections and aplastic anaemia. Intern Med J 2007;37(3):192-5.
16. Tung J, Hadzic N, Layton M, Baker AJ, Dhawan A, Rela M, et al. Bone marrow failure in children with acute liver failure. J Pediatr Gastroenterol Nutr 2000;31(5):557-61.
17. Bultmann BD, Klingel K, Sotlar K, Bock CT, Kandolf R. Parvovirus B19: a pathogen responsible for more than hematologic disorders. Virchows Arch 2003;442(1):8-17.
18. Srivastava A, Lu L. Replication of B19 parvovirus in highly enriched hematopoietic progenitor cells from normal human bone marrow. J Virol 1988;62(8):3059-63.
19. Poole BD, Karetnyi YV, Naides SJ. Parvovirus B19-induced apoptosis of hepatocytes. J Virol 2004;78(14):7775-83.
20. Poole BD, Zhou J, Grote A, Schiffenbauer A, Naides SJ. Apoptosis of liver-derived cells induced by parvovirus B19 nonstructural protein. J Virol 2006;80(8):4114-21.
21. Moffatt S, Yaegashi N, Tada K, Tanaka N, Sugamura K. Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells. J Virol 1998;72(4):3018-28.
22. Hsu TC, Wu WJ, Chen MC, Tsay GJ. Human parvovirus B19 non-structural protein (NS1) induces apoptosis through mitochondria cell death pathway in COS-7 cells. Scand J Infect Dis 2004;36(8):570-7.
23. Fu Y, Ishii KK, Munakata Y, Saitoh T, Kaku M, Sasaki T. Regulation of tumor necrosis factor alpha promoter by human parvovirus B19 NS1 through activation of AP-1 and AP-2. J Virol 2002;76(11):5395-403.
24. Zhi N, Mills IP, Lu J, Wong S, Filippone C, Brown KE. Molecular and functional analyses of a human parvovirus B19 infectious clone demonstrates essential roles for NS1, VP1, and the 11-kilodalton protein in virus replication and infectivity. J Virol 2006;80(12):5941-50.
25. Raab U, Beckenlehner K, Lowin T, Niller HH, Doyle S, Modrow S. NS1 protein of parvovirus B19 interacts directly with DNA sequences of the p6 promoter and with the cellular transcription factors Sp1/Sp3. Virology 2002;293(1):86-93.
26. Jindal HK, Yong CB, Wilson GM, Tam P, Astell CR. Mutations in the NTP-binding motif of minute virus of mice (MVM) NS-1 protein uncouple ATPase and DNA helicase functions. J Biol Chem 1994;269(5):3283-9.
27. Nuesch JP, Christensen J, Rommelaere J. Initiation of minute virus of mice DNA replication is regulated at the level of origin unwinding by atypical protein kinase C phosphorylation of NS1. J Virol 2001;75(13):5730-9.
28. Nuesch JP, Corbau R, Tattersall P, Rommelaere J. Biochemical activities of minute virus of mice nonstructural protein NS1 are modulated In vitro by the phosphorylation state of the polypeptide. J Virol 1998;72(10):8002-12.
29. Nuesch JP, Cotmore SF, Tattersall P. Sequence motifs in the replicator protein of parvovirus MVM essential for nicking and covalent attachment to the viral origin: identification of the linking tyrosine. Virology 1995;209(1):122-35.
30. Christensen J, Tattersall P. Parvovirus initiator protein NS1 and RPA coordinate replication fork progression in a reconstituted DNA replication system. J Virol 2002;76(13):6518-31.
31. Young PJ, Jensen KT, Burger LR, Pintel DJ, Lorson CL. Minute virus of mice NS1 interacts with the SMN protein, and they colocalize in novel nuclear bodies induced by parvovirus infection. J Virol 2002;76(8):3892-904.
32. Cziepluch C, Lampel S, Grewenig A, Grund C, Lichter P, Rommelaere J. H-1 parvovirus-associated replication bodies: a distinct virus-induced nuclear structure. J Virol 2000;74(10):4807-15.
33. Bashir T, Rommelaere J, Cziepluch C. In vivo accumulation of cyclin A and cellular replication factors in autonomous parvovirus minute virus of mice-associated replication bodies. J Virol 2001;75(9):4394-8.
34. Sarkaria JN, Busby EC, Tibbetts RS, Roos P, Taya Y, Karnitz LM, et al. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res 1999;59(17):4375-82.
35. Blasina A, Price BD, Turenne GA, McGowan CH. Caffeine inhibits the checkpoint kinase ATM. Curr Biol 1999;9(19):1135-8.
36. Nicoletti VG, Stella AM. Role of PARP under stress conditions: cell death or protection? Neurochem Res 2003;28(2):187-94.
37. 53 and E2F-1. Adv Enzyme Regul 2000;40:183-215.
38. Wang H, Shimoji M, Yu SW, Dawson TM, Dawson VL. Apoptosis inducing factor and PARP-mediated injury in the MPTP mouse model of Parkinson's disease. Ann N Y Acad Sci 2003;991:132-9.
39. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 2003;3(3):155-68.
40. Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 2003;22(47):7265-79.
41. Op De Beeck A, Caillet-Fauquet P. The NS1 protein of the autonomous parvovirus minute virus of mice blocks cellular DNA replication: a consequence of lesions to the chromatin? J Virol 1997;71(7):5323-9.
42. 21(cip1). J Virol 2001;75(22):11071-8.
43. Lavin MF, Khanna KK. ATM: the protein encoded by the gene mutated in the radiosensitive syndrome ataxia-telangiectasia. Int J Radiat Biol 1999;75(10):1201-14.
44. Flynn RL, Zou L. ATR: a master conductor of cellular responses to DNA replication stress. Trends Biochem Sci. 2010; [Epub ahead of print]
45. Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, et al. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 2002;297(5579):259-63.
46. Cimprich KA, Cortez D. ATR: an essential regulator of genome integrity. Nat Rev Mol Cell Biol 2008;9(8):616-27.
47. 53, Chk1, and histone H2AX phosphorylation in response to hyperoxia: ATR-dependent ATM activation. Am J Physiol Lung Cell Mol Physiol 2008;294(5):L998-L1006.
48. Roos WP, Kaina B. DNA damage-induced cell death by apoptosis. Trends Mol Med 2006;12(9):440-50.
49. Sinclair A, Yarranton S, Schelcher C. DNA-damage response pathways triggered by viral replication. Expert Rev Mol Med 2006;8(5):1-11.
50. Bonvicini F, Filippone C, Manaresi E, Zerbini M, Musiani M, Gallinella G. Functional analysis and quantitative determination of the expression profile of human parvovirus B19. Virology 2008;381(2):168-77.
51. Sol N, Le Junter J, Vassias I, Freyssinier JM, Thomas A, Prigent AF, et al. Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19. J Virol 1999;73(10):8762-70.
52. Nuesch JP, Rommelaere J. NS1 interaction with CKII alpha: novel protein complex mediating parvovirus-induced cytotoxicity. J Virol 2006;80(10):4729-39.
53. Nuesch JP, Rommelaere J. A viral adaptor protein modulating casein kinase II activity induces cytopathic effects in permissive cells. Proc Natl Acad Sci U S A 2007;104(30):12482-7.
54. Hri stov G, Kramer M, Li J, El-Andal oussi N, Mora R, Daeffl er L, et al. Through its nonstructural protein NS1, parvovirus H-1 induces apoptosis via accumulation of reactive oxygen species. J Virol; 2010; 84(12):5909-22.
55. Christensen J, Cotmore SF, Tattersall P. Minute virus of mice initiator protein NS1 and a host KDWK family transcription factor must form a precise ternary complex with origin DNA for nicking to occur. J Virol 2001;75(15):7009-17.
56. Klenerman P, Tolfvenstam T, Price DA, Nixon DF, Broliden K, Oxenius A. T lymphocyte responses against human parvovirus B19: small virus, big response. Pathol Biol (Paris) 2002;50(5):317-25.
57. Bredholt G, Olaussen E, Moens U, Rekvig OP. Linked production of antibodies to mammalian DNA and to human polyomavirus large T antigen: footprints of a common molecular and cellular process? Arthritis Rheum 1999;42(12):2583-92.
58. Rekvig OP, Moens U, Sundsfjord A, Bredholt G, Osei A, Haaheim H, et al. Experimental expression in mice and spontaneous expression in human SLE of polyomavirus T-antigen. A molecular basis for induction of antibodies to DNA and eukaryotic transcription factors. J Clin Invest 1997;99(8):2045-54.
59. Moens U, Seternes OM, Hey AW, Silsand Y, Traavik T, Johansen B, et al. In vivo expression of a single viral DNA-binding protein generates systemic lupus erythematosus-related autoimmunity to double-stranded DNA and histones. Proc Natl Acad Sci U S A 1995;92(26):12393-7.
60. Andreassen K, Moens U, Nossent H, Marion TN, Rekvig OP. Termination of human T cell tolerance to histones by presentation of histones and polyomavirus T antigen provided that T antigen is complexed with nucleosomes. Arthritis Rheum 1999;42(11):2449-60.
61. Zakrzewska K, Azzi A, De Biasi E, Radossi P, De Santis R, Davoli PG, et al. Persistence of parvovirus B19 DNA in synovium of patients with haemophilic arthritis. J Med Virol 2001;65(2):402-7.
62. Mitchell LA, Leong R, Rosenke KA. Lymphocyte recognition of human parvovirus B19 non-structural (NS1) protein: associations with occurrence of acute and chronic arthropathy? J Med Microbiol 2001;50(7):627-35.
63. Kerr JR, Cunniffe VS. Antibodies to parvovirus B19 non-structural protein are associated with chronic but not acute arthritis following B19 infection. Rheumatology (Oxford) 2000;39(8):903-8.